Uses of lipopolysaccharide binding protein

Details Uses of lipopolysaccharide binding protein Uses of lipopolysaccharide binding protein

1997-10-22

1999-11-23

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 435 681, A61K 3800, A61K 3816

Patent

active

059900822

ABSTRACT:
Novel LBP compositions and therapeutic uses for LBP are provided for preventing the adverse effects of exposure to endotoxin.

REFERENCES:
patent: 5245013 (1993-09-01), Ulevitch et al.
patent: 5310879 (1994-05-01), Ulevitch et al.
patent: 5484705 (1996-01-01), White et al.
patent: 5488034 (1996-01-01), McGregor et al.
patent: 5696090 (1997-12-01), McGregor et al.
patent: 5731415 (1998-03-01), Gazzano-Santoro
patent: 5770561 (1998-06-01), Horwitz
patent: 5804367 (1998-09-01), White et al.
Elevated levels of lipopolysaccharide (LPS) binding protein ( LBP) reduce the inflammatory potential of LPS in vitro and in vivo. Fourth International Endotoxin Society Conference, Nagoya, Japan, Oct. 22-25, 1996. Journal of Endotoxin Resear.
Abrahamson, S.L., et al., "Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein," J. Biological Chemistry, 272(4):2149-2155 (Jan., 1997).
Beekhuizen, H. et al., "CD14 Contributes to the Adherence of Human Monocytes to Cytokine-Stimulated Endothelial Cells," J. Immunology, 147(11):3761-3767 (Dec., 1991).
Bone, R.C. "The Pathogenesis of Sepsis," Annals Internal Medicine, 115:457-469 (1991).
Corradin, S.B. et al., "Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein," J. Leukocyte Biology, 52:363-368 (Oct., 1992).
de Winter, R.J. et al., "Recombinant Endotoxin-Binding Protein (rBPI.sub.23) Attenuates Endotoxin-Induced Circulatory Changes in Humans," J. Inflammation, 45: 193-206 (1995).
Dedrick, R.L. et al., "Elevated Levels of Lipopolysaccharide (LPS) Binding Protein (LBP) Reduce the Inflammatory Potential of LPS in Vitro and in Vivo," J. Endotoxin Research, 3(supp. 1):18 (Abstract I-14) (Oct., 1996).
Dubin, W. et al., "Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment," Am. J. Physiol., 270:L736-L744 (1996).
Frey, E.A. et al., "Soluble CD14 Participates in the Response of Cells to Lipopolysaccharide," J. Exp. MEd., 176:1665-1671 (Dec., 1992).
Froon, A.H.M., et al., "Lipopolysaccharide Toxicity-Regulating Proteins in Bacteremia," J. Infectious Diseases, 171:1250-1257 (1995).
Gallay, P. et al., "Purification and Characterization of Murine Lipopolysaccharide-Binding Protein," Infection and Immunity, 61(2):378-383 (Feb., 1993).
Gazzano-Santoro, H. et al., "Competition between rBPI.sub.23, a Recombinant Fragment of Bactericidal/Permeability-Increasing Protein, and Lipopolysaccharide (LPS)-Binding Protein for Binding to LPS and Gram-Negative Bacteria," Infection Immunity, 62(4): 1185-1191 (Apr., 1994).
Gegner, J.A. et al., "Lipopolysaccharide (LPS) Signal Transduction and Clearance," J. Biological Chemistry, 270(10): 5320-5235 (Mar., 1995).
Geller, D.A., et al., "Induction of Hepatocyte Lipopolysaccharide Binding Protein in Models of Sepsis and the Acute-Phase Response," Arch. Surg., 128(1): 22-28 (Jan., 1993).
Hailman, E. et al., "Lipopolysaccharide (LPS)-binding Protein Accelerates the Binding of LPS to CD14," J. Exp. Med., 179(1): 269-277 (Jan., 1994).
Han, J. et al., "Lipopolysaccharide (LPS) Binding Protein, Truncated at the Ile-197, Binds LPS but does not Transfer LPS to CD14," J. Biological Chemistry, 269(11): 8172-8175 (Mar., 1994).
Haziot, A. et al., "Recombinant Soluble CD14 Prevents Mortality in Mice Treated with Endotoxin (Lipopolysaccharide)," J. Immunology, 154: 6529-6532 (1995).
Haziot, A. et al., "Recombinant Soluble CD14 Inhibits LPS-Induced Tumor Necrosis Factor-.alpha. Production by Cells in Whole Blood," J. Immunology, 152: 5868-5876 (1994).
Heumann, D. et al., "Competition between Bacterial/Permeability-Increasing Protein and Lipopolysaccharide-Binding Protein for Lipopolysaccharide Binding to Monocytes," J. Infectious Diseases, 167: 1351-1357 (1993).
Heumann, D. et al., "Radioimmunoassay versus flow cytometric assay to quantify LPS-binding protein (LBP) concentrations in human plasma," J. Immunological Methods, 171:169-176 (1994).
Huang, K. et al., "Lipopolysaccharide-Induced E-Selectin Expression Requires Continuous Presence of LPS and is Inhibited by Bactericidal/Permeability-Increasing Protein," Inflammation, 19(3):389-404 (1995).
Iriye, B.K. et al., "Differences in the Concentration of an Endotoxin Binding Protein Help Explain Sensitivity to Septic Complications in Pregnancy," Am. J. Obstetrics Gynecol., 174(1 pt. 2):390 (1996) (Abstract 291).
Kirkland, T.N. et al., "Analysis of Lipopolysaccharide Binding by CD14," J. Biological Chemistry, 268(33): 24818-24823 (Nov., 1993).
Lee, J-D et al., "Transfection of CD14 into 70Z/3 Cells Dramatically Enhances the Sensitivity to Complexes of Lipopolysaccharides (LPS) and LPS Binding Protein," J. Experimental Medicine, 175:1697-1705 (Jun., 1992).
Leturcq, D. et al, "Generation of Monoclonal Antibodies to Human LBP and Their Use in the Detection of LBP Protein in Serum", J. Cell. Biochem., 16C:161 (1992) (Abstract CB 109).
Little, D. et al., "Perioperative immune modulation," Surgery, 114(1): 87-91 (1993).
Marra, M.N. et al., "The Role of Bactericidal/Permeability--Increasing Protein as a Natural Inhibitor of Bacterial Endotoxin," J. Immunology, 148(2):532-537 (Jan., 1992).
Marra, M.N. et al., "Bactericidal/Permeability--Increasing Protein has Endotoxin-Neutralizing Activity," J. Immunology, 144(2): 662-666 (1990).
Mathison, J.C. et al., "Plasma Lipopolysaccharide (LPS)-Binding Protein," J. Immunology, 149(1):200-206 (Jul. 1, 1992).
Mathison, J. et al., "Regulatory Mechanisms of Host Responsiveness to Endotoxin (Lipopolysaccharide)," Pathobiology, 59:185-188 (1991).
Meszaros, K. et al., "Immunoreactivity and Bioactivity of Lipopolysaccharide-Binding Protein in Normal and Heat-Inactivated Sera," Infection and Immunity, 63(1): 363-366 (Jan., 1995).
Morrison, D.C. et al., "The Effects of Bacterial Endotoxins on Host Mediation Systems," Am. J. Pathology, 93(2):527-618 (Nov., 1978).
Ooi et al., "Endotoxin-Neutralizing Properties of the 25 kD N-Terminal Fragment and a Newly Isolated 30kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-increasing Protein of Human Neutrophils," J. Exp. Med., 174:649-655 (Sep., 1991).
Opal, S.M. et al., "Activity of Lipopolysaccharide-Binding Protein-Bactericidal/Permeability-Increasing Protein Fusion Peptide in an Experimental Model of Pseudomonas Sepsis," Antimicrobial Agents Chemotherapy, 39(12): 2813-2815 (Dec., 1995).
Pugin, J. et al., "Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14," Proc. Natl. Acad. Sci., USA, 90:2744-2748 (Apr., 1993).
Pugin, J. et al., "Soluble CD14 and Lipopolysaccharide Binding Protein Mediate Epithelial Cell Responses to Lipopolysaccharides," FASEB J., A142 (Abstract 824) (1993).
Schindler, R. et al., "Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis," Clinical Nephrology, 40(6):346-351 (1993).
Schumann, R.R. et al., "Significantly Elevated Levels of Lipopolysaccharide Binding Protein (LBP) in Patients with Severe Sepsis: A Prospective Cohort Study with 109 surgical ICU Patients," 36th Int'l Conf. on Antimicrobial Agents and Chemotherapy, New Orleans, LA, Sep. 15-18, (1996) (Abstract LB17).
Schumann et al., "Structure and Function of Lipopolysaccharide Binding Protein", Science, 249:1429-1431 (Sep., 1990).
Schutt, C. et al., "CD14 Prevents Endotoxin Inducible Oxidative Burst Response of Human Monocytes," Allerg. Immunol., 37: 159-164 (1991).
Schutt, C. et al., "Endotoxin-neutralizing capacity of soluble CD14," Res. Immunol., 143: 71-78 (1992).
Taylor, A.H. et al., "Lipopolysaccharide (LPS) Neutralizing Peptides Reveal a Lipid A Binding Site of LPS Binding Protein," J. Biological Chemistry, 270(30): 17934-17938 (Jul., 1995).
Theofan et al., "An Amino-Terminal Fragment of Human Lipopolysaccharide-Binding Protein Retains Lipid A Binding but Not CD14-Stimulatory Activity", J. Immunology, 152(7): 3623-3629 (1994).
Tobias, P.S. et al., "Identification of a Lipid

Affiliated with

Also associated with

Rating

Uses of lipopolysaccharide binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of lipopolysaccharide binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of lipopolysaccharide binding protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1221937